1. The Surveillance, Epidemiology, and End Results (SEER) Program. https://seer.cancer.gov/statfacts/html/urinb.html. Accessed 10 September 2020.
2. Targeting FGFR signaling in cancer;Touat;Clin. Cancer Res.,2015
3. Fibroblast growth factor receptors (FGFRs): Structures and small molecule inhibitors;Dai;Cells,2019
4. Janssen Pharmaceuticals. BALVERSA® (erdafitinib): US prescribing information. 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf. Accessed 1 September 2021.
5. FDA grants accelerated approval to erdafitinib for metastatic urothelial carcinoma. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-erdafitinib-metastatic-urothelial-carcinoma. Accessed 1 September 2021.